9.62 USD
+0.38 (+4.11%)
We assign a fundamental rating of 2 out of 10 to VALN. VALN was compared to 525 industry peers in the Biotechnology industry. VALN has a bad profitability rating. Also its financial health evaluation is rather negative. VALN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- VALN had negative earnings in the past year.
- VALN had a negative operating cash flow in the past year.
- VALN had negative earnings in each of the past 5 years.
- In multiple years VALN reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -26.86%, VALN is in the better half of the industry, outperforming 69.14% of the companies in the same industry.
- VALN's Return On Equity of -80.02% is in line compared to the rest of the industry. VALN outperforms 51.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.86% | ||
| ROE | -80.02% | ||
| ROIC | N/A |
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VALN has a Gross Margin of 46.53%. This is in the better half of the industry: VALN outperforms 74.86% of its industry peers.
- In the last couple of years the Gross Margin of VALN has declined.
- The Profit Margin and Operating Margin are not available for VALN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
2. Health
2.1 Basic Checks
- VALN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for VALN has been increased compared to 1 year ago.
- VALN has more shares outstanding than it did 5 years ago.
- VALN has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -0.10, we must say that VALN is in the distress zone and has some risk of bankruptcy.
- VALN's Altman-Z score of -0.10 is fine compared to the rest of the industry. VALN outperforms 60.19% of its industry peers.
- A Debt/Equity ratio of 0.89 indicates that VALN is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.89, VALN is not doing good in the industry: 73.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.1 |
ROIC/WACCN/A
WACC8.04%
2.3 Liquidity
- VALN has a Current Ratio of 1.78. This is a normal value and indicates that VALN is financially healthy and should not expect problems in meeting its short term obligations.
- VALN's Current ratio of 1.78 is on the low side compared to the rest of the industry. VALN is outperformed by 77.90% of its industry peers.
- A Quick Ratio of 1.36 indicates that VALN should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.36, VALN is not doing good in the industry: 81.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
- VALN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1180.00%.
- VALN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.89%.
- Measured over the past years, VALN shows a small growth in Revenue. The Revenue has been growing by 6.09% on average per year.
EPS 1Y (TTM)-1180%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.43%
Revenue 1Y (TTM)19.89%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%-35.76%
3.2 Future
- Based on estimates for the next years, VALN will show a very strong growth in Earnings Per Share. The EPS will grow by 55.11% on average per year.
- Based on estimates for the next years, VALN will show a quite strong growth in Revenue. The Revenue will grow by 17.00% on average per year.
EPS Next Y-607%
EPS Next 2Y-121.49%
EPS Next 3Y101.1%
EPS Next 5Y55.11%
Revenue Next Year-6.69%
Revenue Next 2Y2.34%
Revenue Next 3Y27.3%
Revenue Next 5Y17%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for VALN. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VALN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- VALN's earnings are expected to grow with 101.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-121.49%
EPS Next 3Y101.1%
5. Dividend
5.1 Amount
- No dividends for VALN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VALNEVA SE - ADR / VALN FAQ
What is the fundamental rating for VALN stock?
ChartMill assigns a fundamental rating of 2 / 10 to VALN.
What is the valuation status for VALN stock?
ChartMill assigns a valuation rating of 1 / 10 to VALNEVA SE - ADR (VALN). This can be considered as Overvalued.
What is the profitability of VALN stock?
VALNEVA SE - ADR (VALN) has a profitability rating of 2 / 10.
How financially healthy is VALNEVA SE - ADR?
The financial health rating of VALNEVA SE - ADR (VALN) is 2 / 10.